• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞低密度脂蛋白受体相关蛋白缺乏增强载脂蛋白E/低密度脂蛋白受体双敲除小鼠的动脉粥样硬化。

Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.

作者信息

Hu L, Boesten L S M, May P, Herz J, Bovenschen N, Huisman M V, Berbée J F P, Havekes L M, van Vlijmen B J M, Tamsma J T

机构信息

Vascular Medicine Unit, Department of General Internal Medicine, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

出版信息

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2710-5. doi: 10.1161/01.ATV.0000249641.96896.e6. Epub 2006 Oct 12.

DOI:10.1161/01.ATV.0000249641.96896.e6
PMID:17038633
Abstract

OBJECTIVE

In vitro studies implicate that the low-density lipoprotein receptor (LDLR)-related protein (LRP) in macrophages has a pro-atherogenic potential. In the present study, we investigated the in vivo role of macrophage specific LRP in atherogenesis independent of its role in the uptake of lipoproteins.

METHODS AND RESULTS

We generated macrophage-specific LRP-deficient mice on an apoE/LDLR double-deficient background. Macrophage LRP deletion did not affect plasma cholesterol and triglyceride levels, lipoprotein distribution, and blood monocyte counts. Nevertheless, macrophage LRP deficiency resulted in a 1.8-fold increase in total atherosclerotic lesion area in the aortic root of 18-week-old mice. Moreover, LRP deficiency also resulted in a relatively higher number of advanced lesions. Whereas macrophage and smooth muscle cell content did not differ between LRP-deficient mice and control littermates, a 1.7-fold increase in collagen content and 2.3-fold decrease in relative number of CD3+ T cells were observed in lesions from macrophage specific LRP-deficient mice.

CONCLUSIONS

Our data demonstrate that independent of its role in lipoprotein uptake, absence of LRP in macrophages resulted in more advanced atherosclerosis and in lesions that contained more collagen and less CD3+ T cells. In contrast to previous in vitro studies, we conclude that macrophage LRP has an atheroprotective potential and may modulate the extracellular matrix in the atherosclerotic lesions.

摘要

目的

体外研究表明,巨噬细胞中的低密度脂蛋白受体(LDLR)相关蛋白(LRP)具有促动脉粥样硬化的潜力。在本研究中,我们研究了巨噬细胞特异性LRP在动脉粥样硬化发生中的体内作用,而不考虑其在脂蛋白摄取中的作用。

方法与结果

我们在载脂蛋白E/LDLR双缺陷背景下培育出巨噬细胞特异性LRP缺陷小鼠。巨噬细胞LRP缺失不影响血浆胆固醇和甘油三酯水平、脂蛋白分布及血液单核细胞计数。然而,巨噬细胞LRP缺陷导致18周龄小鼠主动脉根部的总动脉粥样硬化病变面积增加了1.8倍。此外,LRP缺陷还导致晚期病变数量相对增加。虽然LRP缺陷小鼠与对照同窝小鼠的巨噬细胞和平滑肌细胞含量没有差异,但在巨噬细胞特异性LRP缺陷小鼠的病变中,观察到胶原蛋白含量增加了1.7倍,CD3+T细胞相对数量减少了2.3倍。

结论

我们的数据表明,不考虑其在脂蛋白摄取中的作用,巨噬细胞中LRP的缺失会导致更严重的动脉粥样硬化,以及含有更多胶原蛋白和更少CD3+T细胞的病变。与之前的体外研究相反,我们得出结论,巨噬细胞LRP具有抗动脉粥样硬化的潜力,并可能调节动脉粥样硬化病变中的细胞外基质。

相似文献

1
Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.巨噬细胞低密度脂蛋白受体相关蛋白缺乏增强载脂蛋白E/低密度脂蛋白受体双敲除小鼠的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2710-5. doi: 10.1161/01.ATV.0000249641.96896.e6. Epub 2006 Oct 12.
2
Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent.低密度脂蛋白受体相关蛋白 1 通过限制病变部位的细胞凋亡和炎症性 Ly-6Chigh 单核细胞增多来预防早期动脉粥样硬化:证据表明,这些作用不依赖于载脂蛋白 E。
Circulation. 2011 Jul 26;124(4):454-64. doi: 10.1161/CIRCULATIONAHA.111.032268. Epub 2011 Jul 5.
3
Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation.髓样细胞特异性缺失 Epsins 1 和 2 通过防止 LRP-1 下调来减少动脉粥样硬化。
Circ Res. 2019 Feb 15;124(4):e6-e19. doi: 10.1161/CIRCRESAHA.118.313028.
4
Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.脂肪细胞增强结合蛋白 1(AEBP1)(一种新型巨噬细胞促炎介质)过表达促进并消融减弱 ApoE(-/-)和 LDLR(-/-)小鼠的动脉粥样硬化。
Mol Med. 2011 Sep-Oct;17(9-10):1056-64. doi: 10.2119/molmed.2011.00141. Epub 2011 Jun 14.
5
Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.在缺乏低密度脂蛋白受体的情况下,肝脏载脂蛋白E的表达是残余脂蛋白清除所必需的。
J Clin Invest. 1998 Apr 15;101(8):1726-36. doi: 10.1172/JCI2181.
6
Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.小鼠肝脏低密度脂蛋白受体相关蛋白缺乏会增加动脉粥样硬化,且与血浆胆固醇无关。
Blood. 2004 May 15;103(10):3777-82. doi: 10.1182/blood-2003-11-4051. Epub 2004 Jan 22.
7
Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.溶血磷脂酰胆碱效应器G2A的缺失可改善低密度脂蛋白受体敲除小鼠的主动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2703-9. doi: 10.1161/01.ATV.0000246774.02426.71. Epub 2006 Sep 21.
8
Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.可溶性尿激酶受体(uPAR)在肝脏中的过表达可抑制饮食诱导的低密度脂蛋白受体缺陷(LDLR-/-)小鼠的动脉粥样硬化。
PLoS One. 2015 Aug 27;10(8):e0131854. doi: 10.1371/journal.pone.0131854. eCollection 2015.
9
Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse.巨噬细胞低密度脂蛋白受体相关蛋白的缺失会增加小鼠的动脉粥样硬化形成。
Circ Res. 2007 Mar 16;100(5):670-7. doi: 10.1161/01.RES.0000260204.40510.aa. Epub 2007 Feb 15.
10
Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.巨噬细胞源性载脂蛋白E改善肥胖载脂蛋白E缺陷小鼠的血脂异常和动脉粥样硬化。
Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E284-90. doi: 10.1152/ajpendo.00601.2007. Epub 2007 Nov 20.

引用本文的文献

1
Impacts of systemic milieu on cerebrovascular and brain aging: insights from heterochronic parabiosis, blood exchange, and plasma transfer experiments.全身环境对脑血管和脑衰老的影响:来自异时联体共生、血液交换和血浆转移实验的见解
Geroscience. 2025 May 23. doi: 10.1007/s11357-025-01657-y.
2
Low-density lipoprotein receptor-related protein-1 and nitrative stress in psoriasis vulgaris: a cross-sectional study.寻常型银屑病中低密度脂蛋白受体相关蛋白-1与硝化应激:一项横断面研究
Arch Dermatol Res. 2025 Apr 11;317(1):699. doi: 10.1007/s00403-025-04194-y.
3
Skeletal progenitor LRP1 deficiency causes severe and persistent skeletal defects with Wnt pathway dysregulation.
骨骼祖细胞LRP1缺乏会导致严重且持续的骨骼缺陷,并伴有Wnt信号通路失调。
Bone Res. 2025 Jan 26;13(1):17. doi: 10.1038/s41413-024-00393-x.
4
Endocrine Regulation of Microvascular Receptor-Mediated Transcytosis and Its Therapeutic Opportunities: Insights by PCSK9-Mediated Regulation.微血管受体介导的转胞吞作用的内分泌调节及其治疗机会:PCSK9介导的调节见解
Pharmaceutics. 2023 Apr 18;15(4):1268. doi: 10.3390/pharmaceutics15041268.
5
Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell-cell interactions in the pathophysiology of neurological disease.神经丝氨酸蛋白酶抑制剂,在神经疾病的病理生理学中,是轴突发生、突触建模和细胞间相互作用的关键调节因子。
Cell Mol Life Sci. 2022 Mar 4;79(3):172. doi: 10.1007/s00018-022-04185-6.
6
The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis.低密度脂蛋白受体相关蛋白1在动脉粥样硬化中的双重作用
Front Cardiovasc Med. 2021 May 28;8:682389. doi: 10.3389/fcvm.2021.682389. eCollection 2021.
7
PCSK9 Biology and Its Role in Atherothrombosis.PCSK9 生物学及其在动脉粥样血栓形成中的作用。
Int J Mol Sci. 2021 May 30;22(11):5880. doi: 10.3390/ijms22115880.
8
PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation.前蛋白转化酶枯草溶菌素9在动脉粥样硬化中的作用并不局限于对血浆低密度脂蛋白胆固醇的调节。
Front Cardiovasc Med. 2021 Mar 23;8:639727. doi: 10.3389/fcvm.2021.639727. eCollection 2021.
9
Lrp1 Regulation of Pulmonary Function. Follow-Up of Human GWAS in Mice.LRP1 对肺功能的调节。在小鼠中对人类 GWAS 的随访。
Am J Respir Cell Mol Biol. 2021 Mar;64(3):368-378. doi: 10.1165/rcmb.2019-0444OC.
10
Lipoprotein receptor signalling in atherosclerosis.载脂蛋白受体信号通路与动脉粥样硬化
Cardiovasc Res. 2020 Jun 1;116(7):1254-1274. doi: 10.1093/cvr/cvz338.